Gross Profit Summary of Bioasis Technologies Inc.

Bioasis Technologies Inc.'s latest annual gross profit in 2023 was - CAD , up 100.0% from previous year.
Bioasis Technologies Inc.'s latest quarterly gross profit in 2024 Q2 was - CAD , down 0.0% from previous quarter.
Bioasis Technologies Inc. reported a annual gross profit of -17.19 Thousand CAD in annual gross profit 2022, down -100.61% from previous year.
Bioasis Technologies Inc. reported a annual gross profit of 2.84 Million CAD in annual gross profit 2021, up 368.35% from previous year.
Bioasis Technologies Inc. reported a quarterly gross profit of - CAD for 2024 Q1, down 0.0% from previous quarter.
Bioasis Technologies Inc. reported a quarterly gross profit of -71.91 Thousand CAD for 2023 Q3, down -180.7% from previous quarter.

Annual Gross Profit Chart of Bioasis Technologies Inc. (2023 - 2007)

Historical Annual Gross Profit of Bioasis Technologies Inc. (2023 - 2007)

Year	Gross Profit	Gross Profit Growth
2023	- CAD	100.0%
2022	-17.19 Thousand CAD	-100.61%
2021	2.84 Million CAD	368.35%
2020	606.38 Thousand CAD	-57.04%
2019	1.41 Million CAD	1057.27%
2018	121.97 Thousand CAD	46.76%
2017	83.11 Thousand CAD	252.01%
2016	-54.67 Thousand CAD	0.0%
2015	- CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	0.0%
2007	- CAD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	- CAD	0.0%
2024 Q1	- CAD	0.0%
2023 Q3	-71.91 Thousand CAD	-180.7%
2023 Q1	-13.5 Thousand CAD	1.09%
2023 FY	- CAD	100.0%
2023 Q4	- CAD	100.0%
2023 Q2	89.11 Thousand CAD	759.79%
2022 Q2	-13.65 Thousand CAD	2.21%
2022 FY	-17.19 Thousand CAD	-100.61%
2022 Q4	-13.65 Thousand CAD	-136.2%
2022 Q1	-13.95 Thousand CAD	0.16%
2022 Q3	37.72 Thousand CAD	376.37%
2021 Q2	4.07 Million CAD	0.0%
2021 FY	2.84 Million CAD	368.35%
2021 Q1	- CAD	-100.0%
2021 Q3	- CAD	-100.0%
2021 Q4	-13.98 Thousand CAD	0.0%
2020 Q1	192.36 Thousand CAD	29.22%
2020 Q4	36.95 Thousand CAD	-79.86%
2020 FY	606.38 Thousand CAD	-57.04%
2020 Q3	183.48 Thousand CAD	-6.48%
2020 Q2	196.2 Thousand CAD	2.0%
2019 Q1	38.42 Thousand CAD	118.67%
2019 Q2	- CAD	-100.0%
2019 Q4	148.86 Thousand CAD	-87.84%
2019 Q3	1.22 Million CAD	0.0%
2019 FY	1.41 Million CAD	1057.27%
2018 FY	121.97 Thousand CAD	46.76%
2018 Q4	-205.79 Thousand CAD	-510.5%
2018 Q3	50.13 Thousand CAD	-56.75%
2018 Q2	115.92 Thousand CAD	-39.54%
2018 Q1	191.72 Thousand CAD	1318.79%
2017 Q4	13.51 Thousand CAD	-33.74%
2017 FY	83.11 Thousand CAD	252.01%
2017 Q3	20.39 Thousand CAD	-53.09%
2017 Q1	5732.00 CAD	104.89%
2017 Q2	43.47 Thousand CAD	658.46%
2016 Q3	-11.16 Thousand CAD	0.0%
2016 Q4	-117.27 Thousand CAD	-950.74%
2016 FY	-54.67 Thousand CAD	0.0%
2016 Q2	- CAD	0.0%
2016 Q1	- CAD	0.0%
2015 FY	- CAD	0.0%
2015 Q4	- CAD	0.0%
2015 Q3	- CAD	0.0%
2015 Q2	- CAD	0.0%
2015 Q1	- CAD	0.0%
2014 FY	- CAD	0.0%
2014 Q4	- CAD	0.0%
2014 Q3	- CAD	0.0%
2014 Q2	- CAD	0.0%
2014 Q1	- CAD	0.0%
2013 Q1	- CAD	0.0%
2013 Q4	- CAD	0.0%
2013 Q2	- CAD	0.0%
2013 Q3	- CAD	0.0%
2013 FY	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 FY	- CAD	0.0%
2012 Q4	- CAD	0.0%
2012 Q3	- CAD	0.0%
2012 Q1	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 Q1	- CAD	0.0%
2011 Q2	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q4	- CAD	0.0%
2010 Q2	- CAD	0.0%
2010 FY	- CAD	0.0%
2010 Q3	- CAD	0.0%
2010 Q1	- CAD	0.0%
2010 Q4	- CAD	0.0%
2009 Q1	- CAD	0.0%
2009 FY	- CAD	0.0%
2009 Q3	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 Q2	- CAD	0.0%
2008 FY	- CAD	0.0%
2008 Q3	- CAD	0.0%
2008 Q4	- CAD	0.0%
2008 Q1	- CAD	0.0%
2008 Q2	- CAD	0.0%
2007 FY	- CAD	0.0%

Peer Gross Profit Comparison of Bioasis Technologies Inc.

Name	Gross Profit	Gross Profit Difference
Evofem Biosciences, Inc.	11.7 Million USD	100.0%
Arch Therapeutics, Inc.	-2439.00 USD	100.0%
CSL Limited	7.56 Billion USD	100.0%
Santhera Pharmaceuticals Holding AG	119.1 Million USD	100.0%
Regen BioPharma, Inc.	176.56 Thousand USD	100.0%
BioStem Technologies, Inc.	15.42 Million USD	100.0%
Capstone Therapeutics Corp.	9.61 Million USD	100.0%
Qrons Inc.	- USD	NaN%
Nascent Biotech, Inc.	-319.5 Thousand USD	100.0%
Northwest Biotherapeutics, Inc.	-25.79 Million USD	100.0%
Oncotelic Therapeutics, Inc.	70 Thousand USD	100.0%
Skye Bioscience, Inc.	-124.25 Thousand USD	100.0%
ProtoKinetix, Incorporated	-48.25 Thousand USD	100.0%
Rebus Holdings, Inc.	- USD	NaN%
Acro Biomedical Co., Ltd.	140.5 Thousand USD	100.0%
Burzynski Research Institute, Inc.	- USD	NaN%
Genscript Biotech Corporation	409.55 Million USD	100.0%
Neon Bloom, Inc.	- USD	NaN%
Adynxx, Inc.	- USD	NaN%
Eiger BioPharmaceuticals, Inc.	14.99 Million USD	100.0%
Nanobac Pharmaceuticals, Incorporated	3102.00 USD	100.0%
Institute of Biomedical Research Corp.	- USD	NaN%
SQZ Biotechnologies Company	9.79 Million USD	100.0%
Intellipharmaceutics International Inc.	65.72 Thousand USD	100.0%
Propanc Biopharma, Inc.	-34.15 Thousand USD	100.0%
Mesoblast Limited	-35.16 Million USD	100.0%
Marizyme, Inc.	457.7 Thousand USD	100.0%
Genus plc	178.7 Million USD	100.0%
VioQuest Pharmaceuticals, Inc.	- USD	NaN%
Pharming Group N.V.	220.1 Million USD	100.0%
Therapeutic Solutions International, Inc.	62.22 Thousand USD	100.0%
CNBX Pharmaceuticals Inc.	410.16 Thousand USD	100.0%
Nymox Pharmaceutical Corporation	-11 Thousand USD	100.0%
ContraFect Corporation	-154 Thousand USD	100.0%
PsyBio Therapeutics Corp.	-50 Thousand USD	100.0%
Sienna Biopharmaceuticals, Inc.	- USD	NaN%
RegeneRx Biopharmaceuticals, Inc.	76.76 Thousand USD	100.0%
IMV Inc.	-962.29 Thousand USD	100.0%
AXIM Biotechnologies, Inc.	-387.5 Thousand USD	100.0%
MultiCell Technologies, Inc.	49.32 USD	100.0%
ONE Bio Corp.	20.12 Million USD	100.0%
Accustem Sciences Inc.	- USD	NaN%
RVL Pharmaceuticals plc	40.26 Million USD	100.0%
Arno Therapeutics, Inc.	- USD	NaN%
EV Biologics, Inc.	48.9 Thousand USD	100.0%
Q BioMed Inc.	-8988.00 USD	100.0%
Emmaus Life Sciences, Inc.	28.25 Million USD	100.0%
Mosaic ImmunoEngineering Inc.	- USD	NaN%
Biomind Labs Inc.	-15.42 Thousand USD	100.0%
American Oriental Bioengineering, Inc.	44.35 Million USD	100.0%
Provectus Biopharmaceuticals, Inc.	-1.14 Million USD	100.0%
TetraLogic Pharmaceuticals Corporation	- USD	NaN%
GlobeStar Therapeutics Corporation	- USD	NaN%
THC Farmaceuticals, Inc.	-4952.00 USD	100.0%
Curative Biotechnology, Inc.	-97.51 Thousand USD	100.0%
GB Sciences, Inc.	-624.00 USD	100.0%
Alpha Cognition Inc.	-86.02 Thousand USD	100.0%
HST Global, Inc.	- USD	NaN%
Wesana Health Holdings Inc.	- USD	NaN%
Halberd Corporation	-208.00 USD	100.0%
Enzolytics Inc.	30.7 Thousand USD	100.0%
Agentix Corp.	- USD	NaN%
Resverlogix Corp.	- USD	NaN%
Nuo Therapeutics, Inc.	482.43 Thousand USD	100.0%
MetaStat, Inc.	- USD	NaN%
argenx SE	1.1 Billion USD	100.0%
Enzon Pharmaceuticals, Inc.	- USD	NaN%
Endonovo Therapeutics, Inc.	-514.51 Thousand USD	100.0%
RespireRx Pharmaceuticals Inc.	- USD	NaN%
GeneThera, Inc.	- USD	NaN%
Inhibitor Therapeutics, Inc.	- USD	NaN%
AVAX Technologies, Inc.	617.38 Thousand USD	100.0%
Zenith Capital Corp.	- USD	NaN%
Ember Therapeutics, Inc.	- USD	NaN%
Anthera Pharmaceuticals, Inc.	- USD	NaN%
Sigyn Therapeutics, Inc.	-8856.00 USD	100.0%
WPD Pharmaceuticals Inc.	- USD	NaN%
Cotinga Pharmaceuticals Inc.	-83.84 Thousand USD	100.0%
Kadimastem Ltd	-630.13 Thousand USD	100.0%
Helix BioMedix, Inc.	987.98 Thousand USD	100.0%
VitaSpring Biomedical Co. Ltd.	- USD	NaN%
Oncology Pharma Inc.	- USD	NaN%
Reve Technologies, Inc.	- USD	NaN%
LadRx Corporation	-11.83 Thousand USD	100.0%
Cell Source, Inc.	- USD	NaN%
Regen BioPharma, Inc.	176.56 Thousand USD	100.0%
NovAccess Global Inc.	- USD	NaN%
Affymax, Inc.	1.35 Million USD	100.0%
Itoco Inc.	- USD	NaN%
Rasna Therapeutics, Inc.	- USD	NaN%
Pathfinder Cell Therapy, Inc.	- USD	NaN%
Mobile Lads Corp.	- USD	NaN%
CytoDyn Inc.	-29 Thousand USD	100.0%
Claritas Pharmaceuticals, Inc.	- USD	NaN%
NDT Pharmaceuticals Inc.	- USD	NaN%
NanoSphere Health Sciences Inc.	- USD	NaN%
Alseres Pharmaceuticals, Inc.	450.04 Thousand USD	100.0%
SYBLEU INC	11.69 Thousand USD	100.0%
Advanced Proteome Therapeutics Corporation	- USD	NaN%
ImmunoCellular Therapeutics, Ltd.	- USD	NaN%
International Stem Cell Corporation	4.6 Million USD	100.0%
Bioxytran, Inc.	-8285.00 USD	100.0%
GlobeImmune, Inc.	- USD	NaN%
Predictive Technology Group, Inc.	- USD	NaN%
ProText Mobility, Inc.	- USD	NaN%
Cardax, Inc.	- USD	NaN%
VG Life Sciences Inc.	- USD	NaN%
Kaleido Biosciences, Inc.	- USD	NaN%
Advaxis, Inc.	- USD	NaN%
Adhera Therapeutics, Inc.	- USD	NaN%
RenovaCare, Inc.	- USD	NaN%
Regnum Corp.	- USD	NaN%
Innovation Pharmaceuticals Inc.	-373 Thousand USD	100.0%
Neutra Corp.	14.33 Thousand USD	100.0%
Windtree Therapeutics, Inc.	-82 Thousand USD	100.0%
PureTech Health plc	-1.6 Million USD	100.0%
Coeptis Therapeutics, Inc.	-1 Million USD	100.0%
IXICO plc	3.27 Million USD	100.0%
IntelGenx Technologies Corp.	-694 Thousand USD	100.0%
Gelesis Holdings, Inc.	-1.79 Million USD	100.0%
CSL Limited	7.7 Billion USD	100.0%
Cellectis S.A.	18 Thousand USD	100.0%

Global Stocks Search

Bioasis Technologies Inc. (BIOAF)

Gross Profit Summary of Bioasis Technologies Inc.

Annual Gross Profit Chart of Bioasis Technologies Inc. (2023 - 2007)

Historical Annual Gross Profit of Bioasis Technologies Inc. (2023 - 2007)

Peer Gross Profit Comparison of Bioasis Technologies Inc.